McDonald's

McDonald’s announces a strategic offensive and plans to invest about $8.5 billion through 2036, roughly $5 billion of it by 2030, to bring customers back to its restaurants. In response to the trend toward GLP‑1 medications, the company is introducing smaller portions and more protein‑rich offerings such as bowls, grilled chicken sandwiches, wraps and egg bites. Funds will also go toward AI solutions and renovating outlets to adapt to changing eating habits. » More on t-online.de

McDonald’s is responding to the trend toward GLP-1 drugs like Ozempic with a new menu offering more protein and smaller portions. Planned items include bowls, grilled chicken sandwiches, wraps and egg bites; portion sizes will be adjusted. By 2036 the company plans to invest about $8.5 billion, roughly $5 billion of which by 2030, and additional funds will go to AI solutions and restaurant renovations. » More on t-online.de

McDonald’s is using a pricing engine from Tiger Analytics in the U.S. and on initial overseas markets that dynamically sets location-specific prices and is intended to optimize revenue. The technology is producing pronounced price differences within short distances and is causing tensions with franchisees, who are defending margins amid rising costs. Corporate pressure for price discipline and the shared use of algorithms raise antitrust questions, while falling customer traffic increases the risk of a negative customer reaction. » More on deraktionaer.de